COMPARATIVE EFFECTS OF SOME SERUM COMPONENTS AND PROTEOLYTIC PRODUCTSOF FIBRINOGEN ON SURFACE TENSION-LOWERING ABILITIES OF BERACTANT AND A SYNTHETIC PEPTIDE-CONTAINING SURFACTANT KL(4)(1)
E. Manalo et al., COMPARATIVE EFFECTS OF SOME SERUM COMPONENTS AND PROTEOLYTIC PRODUCTSOF FIBRINOGEN ON SURFACE TENSION-LOWERING ABILITIES OF BERACTANT AND A SYNTHETIC PEPTIDE-CONTAINING SURFACTANT KL(4)(1), Pediatric research, 39(6), 1996, pp. 947-952
The serum components of C-reactive protein, lysophosphatidylcholine, f
ibrinogen, and fibrinogen proteolytic products have been shown to redu
ce surface tension-lowering abilities of lung surfactant. The inhibito
ry effects of these serum components were compared among four differen
t surfactants: natural lung surfactant, a phospholipid mixture that ha
d no surfactant proteins, KL(4) surfactant which has a synthetic surfa
ctant protein B (SP-B)-like peptide, and beractant (BER) which has bot
h SP-B and SP-C. The pulsating bubble surfactometer was used to measur
e the surface tension of these surfactants after the addition of inhib
itors. Inhibition of BER and KL(4) surfactant was observed with some s
erum components within 1 min of pulsation, but was reversed after 3 mi
n of pulsation for KL(4) surfactant and to a lesser extent with BER. T
he surface tension of phospholipid mixture alone was significantly inc
reased and did not improve with further pulsations, Natural lung surfa
ctant was least inhibited and was affected only at very high fibrinoge
n concentrations (5 mg/mL), At identical concentrations of these inhib
itors, KL(4) surfactant was inhibited less compared with BER. We concl
ude that the response of a lung surfactant to inhibitory agents may de
pend on the presence or absence of surfactant-related protein(s) in th
e surfactant and the concentration of exogenous surfactant used. KL(4)
surfactant, which has a synthetic peptide in lieu of SP-B, resists in
hibition to these serum components more than BER at similar phospholip
id concentrations.